2 completed, 1 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
Follow Midazolam 2 mg: new trials by email Literature Review of Midazolam 2 mg trials Research Report on Midazolam 2 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis Ustekinumab IV Infusion, Ustekinumab SC Injection, Midazolam 2 mg - Crohn Disease, Ulcerative Colitis | Phase 1 | Terminated | Janssen Research & Development, LLC | 28 | 2018-02-02 | 2025-08-21 |
| A Study to Evaluate the Effect of Oral Doses of JNJ-54175446 on the Inhibition of Cytochrome P450 CYP3A4, CYP2C9, CYP1A2 and CYP2D6 Activity and the Induction of CYP2B6 and CYP2C19 Activity Using a Multiple Probe Substrate Cocktail in Healthy Subjects JNJ-54175446 150 mg, JNJ-54175446 600 mg, Midazolam 2 mg - Healthy | Phase 1 | Completed | Janssen Research & Development, LLC | 16 | 2017-03-14 | 2017-06-08 |
| A Midazolam Drug Interaction Study With PF-04171327 PF-04171327 25 mg, Midazolam 2 mg - Healthy Volunteers | Phase 1 | Completed | Pfizer | 12 | 2009-09-01 | 2009-12-08 |
Colitis, Ulcerative (1) · Crohn Disease (1)
Janssen Research & Development, LLC (2) · Pfizer (1)
Belgium (2) · United States (2) · Germany (1) · United Kingdom (1)
2016 (1), 2017 (1)